|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Short-term investments | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Property and equipment, net | ||||
| Long-term investments | ||||
| Restricted cash | ||||
| Right of use asset | ||||
| Other assets | ||||
| Total assets | ||||
| Liabilities and Stockholders' Equity | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Lease liability - current | ||||
| Deferred grant earnings | ||||
| Total current liabilities | ||||
| Lease liability - noncurrent | ||||
| Total long-term liabilities | ||||
| Total liabilities | ||||
| Redeemable convertible preferred stock | ||||
| Series D Redeemable Convertible Preferred Stock | ||||
| Series C Redeemable Convertible Preferred Stock | ||||
| Series B-1 Redeemable Convertible Preferred Stock | ||||
| Series B Redeemable Convertible Preferred Stock | ||||
| Series A-1 Redeemable Convertible Preferred Stock | ||||
| Series A Redeemable Convertible Preferred Stock | ||||
| Stockholders' equity: | ||||
| Common stock, $0.0001 par value per share; 500,000,000 shares authorized at June 30, 2026 and December 31, 2025; 45,436,867 and 44,024,088 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||
| Additional paid-in-capital | ||||
| Accumulated other comprehensive loss | ||||
| Accumulated deficit | ||||
| Total stockholders' equity | ||||
| Total liabilities and stockholders' equity |
Loading...
